FUNDING HOPE FOR THE FUTURE

FOR YOUNG SARCOMA PATIENTS

OUR VISION

The Cooper Rice-Brading Foundation (CRBF) aims to provide long-term funding to facilitate the cutting edge clinical research required to find a cure for sarcoma. We also recognise the importance of the patient care, and as such, we aim to work with patient care providers and cancer facilities to provide a vastly improved cancer journey for all sarcoma patients.
Current government funding for sarcoma is less than 1%
Sarcoma accounts for 20% of childhood cancers
40% increase in diagnoses compared to the previous decade
Only two in five sarcoma patients survive
100% of CRBF donations directed to funding sarcoma research

MISSION

CRBF will utilise the knowledge, reach and commitment of our Board and supporters to work with government agencies, cancer foundations and organisations, and expand alliances with specialist professional bodies, to enhance the team approach required to deliver the solutions currently eluding our most brilliant medical minds.

SARCOMA

Sarcomas are malignant tumours of the connective tissue, and may be found anywhere in the body. Connective tissue includes fat, blood vessels, nerves, bones, muscles, deep skin tissues, and cartilage. Sarcomas are divided into two main groups, bone sarcomas and soft tissue sarcomas. They are further sub-classified based on the cell type found in the tumour, sharing certain microscopic characteristics.

Sarcomas can develop in children and adults, however they disproportionately affect children and young adults, accounting for 20% of childhood cancers. Of those patients diagnosed with sarcoma, only two in five will survive. Those who do survive may have long term disabilities from their treatments.

There are over 50 subtypes of sarcomas all requiring a specific multi-disciplinary approach to treatment.

COOPER RICE-BRADING
Great Hall, University Of Sydney
(November 2016)

NRL Legends of League Dinner to benefit
Clinical Research for Sarcoma

Logo